High-risk HPV infection after five years in a population-based cohort of Chilean women
dc.contributor.author | Ferreccio Readi, Catterina | |
dc.contributor.author | Van De Wyngard, Vanessa | |
dc.contributor.author | Domínguez, M. A. | |
dc.contributor.author | Puschel Illanes, Klaus | |
dc.contributor.author | Corvalán R., Alejandro | |
dc.contributor.author | Olcay, Fabiola | |
dc.contributor.author | Franceschi, Silvia | |
dc.contributor.author | Snijders, Peter J. | |
dc.contributor.author | Ferreccio Readi, Catterina | |
dc.contributor.author | Van De Wyngard, Vanessa | |
dc.contributor.author | Domínguez, M. A. | |
dc.contributor.author | Puschel Illanes, Klaus | |
dc.contributor.author | Corvalán R., Alejandro | |
dc.contributor.author | Olcay, Fabiola | |
dc.contributor.author | Franceschi, Silvia | |
dc.contributor.author | Snijders, Peter J. | |
dc.date.accessioned | 2019-10-17T15:42:15Z | |
dc.date.available | 2019-10-17T15:42:15Z | |
dc.date.issued | 2011 | |
dc.date.updated | 2019-10-14T18:51:31Z | |
dc.description.abstract | Abstract Background The need to review cervical cancer prevention strategies has been triggered by the availability of new prevention tools linked to human papillomavirus (HPV): vaccines and screening tests. To consider these innovations, information on HPV type distribution and natural history is necessary. This is a five-year follow-up study of gynecological high-risk (HR) HPV infection among a Chilean population-based cohort of women. Findings A population-based random sample of 969 women from Santiago, Chile aged 17 years or older was enrolled in 2001 and revisited in 2006. At both visits they answered a survey on demographics and sexual history and provided a cervical sample for HPV DNA detection (GP5+/6+ primer-mediated PCR and Reverse line blot genotyping). Follow-up was completed by 576 (59.4%) women; 45 (4.6%) refused participation; most losses to follow-up were women who were unreachable, no longer eligible or had missing samples. HR-HPV prevalence increased by 43%. Incidence was highest in women < 20 years of age (19.4%) and lowest in women > 70 (0%); it was three times higher among women HR-HPV positive versus HPV negative at baseline (25.5% and 8.3%; OR 3.8, 95% CI 1.8-8.0). Type-specific persistence was 35.3%; it increased with age, from 0% in women < 30 years of age to 100% in women > 70. An enrollment Pap result ASCUS or worse was the only risk factor for being HR-HPV positive at both visits. Conclusions HR-HPV prevalence increased in the study population. All HR-HPV infections in women < 30 years old cleared, supporting the current recommendation of HR-HPV screening for women > 30 years. | |
dc.fuente.origen | Biomed Central | |
dc.identifier.citation | Infectious Agents and Cancer. 2011 Nov 16;6(1):21 | |
dc.identifier.doi | 10.1186/1750-9378-6-21 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/26786 | |
dc.issue.numero | No. 21 | |
dc.language.iso | en | |
dc.pagina.final | 6 | |
dc.pagina.inicio | 1 | |
dc.revista | Infectious Agents and Cancer | es_ES |
dc.rights | acceso abierto | |
dc.rights.holder | Ferreccio et al; licensee BioMed Central Ltd. | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.other | Cáncer de cuello uterino - Prevención y control | es_ES |
dc.subject.other | Virus del Papiloma - Chile | es_ES |
dc.subject.other | Infecciones bacterianas | es_ES |
dc.title | High-risk HPV infection after five years in a population-based cohort of Chilean women | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 6 | |
sipa.codpersvinculados | 99684 | |
sipa.codpersvinculados | 83957 | |
sipa.codpersvinculados | 63885 |